Skip to main content
NVDA$221.56▲1.3%GOOGL$388.47▲0.3%GOOG$384.70▲0.0%AAPL$301.72▲1.1%MSFT$420.04▲0.9%AMZN$264.98▲2.2%TSM$401.17▲2.3%AVGO$417.76▲1.6%TSLA$415.81▲3.3%META$604.49▲0.4%BRK.A$720,840.00▲0.0%BRK.B$480.90▲0.1%WMT$131.27▼2.5%LLY$1,017.68▼0.3%MU$727.57▲4.8%NVDA$221.56▲1.3%GOOGL$388.47▲0.3%GOOG$384.70▲0.0%AAPL$301.72▲1.1%MSFT$420.04▲0.9%AMZN$264.98▲2.2%TSM$401.17▲2.3%AVGO$417.76▲1.6%TSLA$415.81▲3.3%META$604.49▲0.4%BRK.A$720,840.00▲0.0%BRK.B$480.90▲0.1%WMT$131.27▼2.5%LLY$1,017.68▼0.3%MU$727.57▲4.8%

About Atrium Therapeutics, Inc. (RNA)

Atrium Therapeutics, Inc. (RNA) is a publicly traded company in the Healthcare sector, specifically in the Biotechnology industry. View real-time stock data, AI analysis, options flow, and convergence signals for RNA on iGotFomo.

RNA Key Statistics

0
RNA key financial statistics
Current Price$12.72Market Cap$218 million
Daily Change-1.78%Volume38K
52-Week High$16.7752-Week Low$11.95
SectorHealthcareIndustryBiotechnology

Frequently Asked Questions About RNA

What is Atrium Therapeutics, Inc. (RNA)?
Atrium Therapeutics, Inc. (RNA) is a publicly traded company in the Healthcare sector, operating in the Biotechnology industry.
What is the current RNA stock price?
As of the latest trading session, RNA trades at $12.72 per share, with a daily change of -1.78%.
What is RNA's market capitalization?
Atrium Therapeutics, Inc. has a market capitalization of $218 million, making it a micro-cap stock.
What sector does RNA belong to?
Atrium Therapeutics, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry. View all Healthcare stocks.